Juana María García-Pedrero

36PUBLICATIONS
95CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 28, 2026
Hippo-YAP Pathway Dysregulation and Prognostic Implications in HPV-Negative Oropharyngeal Carcinomas.

|Jun 12, 2026
Clinicopathological Significance of Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.

|Apr 06, 2026
Prognostic Utility of Hematological Inflammatory Markers in Stratifying Cancer Risk in Laryngeal Premalignant Lesions.

María Puente-Vérez, Raúl Martín-González, Daniel Pedregal-Mallo

|Jan 12, 2026
Inactivation of Focal Adhesion Kinase FAK Rapidly Abrogates Keratinocyte Entry in Mitosis via Rho-Associated Kinase, Resulting in Squamous Differentiation.

Lizbeth Contreras, Lorena García-Gaipo, Fe García-Reija

|Nov 05, 2025
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancer.

María Otero-Rosales, Miguel Álvarez-González, Irene Pazos

|Sep 09, 2025
Reply letter: comment on "Treatment package time (TPT) and surgery to post-operative radiotherapy (S-PORT) interval in head and neck cancers: A systematic review and meta-analysis".

Mario Sanchez-Canteli, Juana M García-Pedrero, Juan P Rodrigo

Pageof 6

Frequent Collaborators

29 joint publications

Juana M García-Pedrero

12 joint publications

Juan Carlos de Vicente

11 joint publications

Francisco Hermida-Prado

7 joint publications

Eva Allonca